Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Baxter
Boehringer Ingelheim
QuintilesIMS
Moodys
McKinsey
Johnson and Johnson
Accenture
Dow

Generated: July 22, 2018

DrugPatentWatch Database Preview

Diatrizoate meglumine - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for diatrizoate meglumine and what is the scope of diatrizoate meglumine freedom to operate?

Diatrizoate meglumine
is the generic ingredient in thirty-one branded drugs marketed by Bayer Hlthcare, Bracco, Ge Healthcare, Intl Medication, Mallinckrodt, and Liebel-flarsheim, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for diatrizoate meglumine. One supplier is listed for this compound.
Pharmacology for diatrizoate meglumine
Medical Subject Heading (MeSH) Categories for diatrizoate meglumine

US Patents and Regulatory Information for diatrizoate meglumine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare UROVIST MEGLUMINE DIU/CT diatrizoate meglumine INJECTABLE;INJECTION 087739-001 Sep 23, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bracco RENOVIST diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 010040-020 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bracco RENOVIST II diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 010040-019 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bracco RENOGRAFIN-76 diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 010040-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Dow
Fuji
Johnson and Johnson
Federal Trade Commission
Daiichi Sankyo
Cantor Fitzgerald
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.